ANAB (ANAB) Stock Price & Analysis
ANAB (ANAB) fell 1.15% to USD 56.8 as of September 8, 2026 at 05:43 UTC, according to Nexqual real-time market data.
ANAB last closed at USD 56.8; the session ranged USD 56.1–58.77 on volume of 1,061,882 shares. Market capitalization is —, with a 52-week range of USD 11.4–72.36 (NMS). Source: Nexqual, September 8, 2026 at 05:43 UTC.
Key Statistics (as of September 8, 2026 at 05:43 UTC)
| Price | USD 56.8 |
|---|---|
| Change | ▼ 1.15% (down) |
| Previous Close | USD 56.8 |
| Open | USD 56.8 |
| Day Range | USD 56.1 – 58.77 |
| 52-Week Range | USD 11.4 – 72.36 |
| Volume | 1,061,882 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ANAB)
Nexqual's technical model rates ANAB "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:43 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 51.3 (neutral) |
| vs SMA50 | Below (USD 58.18) |
| MACD | -0.09 (negative) |
From ANAB's Latest SEC 10-K Filing (filed 2026-03-03)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XNCR | Xencor, Inc. | USD 26.61 | ▼ 1.08% |
| RYTM | Rhythm Pharmaceuticals, Inc. | USD 102.74 | ▼ 2.54% |
| KURA | Kura Oncology, Inc. | USD 13.25 | ▲ 1.07% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| SNDX | Syndax Pharmaceuticals, Inc. | USD 20.56 | ▼ 1.06% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:43 UTC. This page is informational and not investment advice.